CN1099876C - Medicine for curing psoriasis - Google Patents
Medicine for curing psoriasis Download PDFInfo
- Publication number
- CN1099876C CN1099876C CN00100276A CN00100276A CN1099876C CN 1099876 C CN1099876 C CN 1099876C CN 00100276 A CN00100276 A CN 00100276A CN 00100276 A CN00100276 A CN 00100276A CN 1099876 C CN1099876 C CN 1099876C
- Authority
- CN
- China
- Prior art keywords
- medicine
- radix
- root
- grams
- parapsoriasis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 24
- 229940079593 drug Drugs 0.000 title description 6
- 201000004681 Psoriasis Diseases 0.000 title description 5
- 206010033898 parapsoriasis Diseases 0.000 claims abstract description 5
- 241000628997 Flos Species 0.000 claims description 6
- 241000255791 Bombyx Species 0.000 claims description 5
- 240000005979 Hordeum vulgare Species 0.000 claims description 5
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 5
- 239000009636 Huang Qi Substances 0.000 claims description 5
- 239000010231 banlangen Substances 0.000 claims description 5
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 5
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000255789 Bombyx mori Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 241000931705 Cicada Species 0.000 abstract 1
- 241000209205 Coix Species 0.000 abstract 1
- 241000576429 Forsythia suspensa Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 208000002474 Tinea Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 4
- 241000893966 Trichophyton verrucosum Species 0.000 description 3
- 241000130764 Tinea Species 0.000 description 2
- 230000002682 anti-psoriatic effect Effects 0.000 description 2
- 229940030999 antipsoriatics Drugs 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- JGQGCJKPBAYEHO-UHFFFAOYSA-N 1-(morpholin-4-ylmethyl)-4-[2-[4-(morpholin-4-ylmethyl)-3,5-dioxopiperazin-1-yl]ethyl]piperazine-2,6-dione Chemical compound C1C(=O)N(CN2CCOCC2)C(=O)CN1CCN(CC1=O)CC(=O)N1CN1CCOCC1 JGQGCJKPBAYEHO-UHFFFAOYSA-N 0.000 description 1
- GBLIGNUYGOFIKS-UHFFFAOYSA-N 4-[2-(3,5-dioxopiperazin-1-yl)ethyl]piperazine-2,6-dione Chemical compound C1C(=O)NC(=O)CN1CCN1CC(=O)NC(=O)C1 GBLIGNUYGOFIKS-UHFFFAOYSA-N 0.000 description 1
- 206010005913 Body tinea Diseases 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 206010067197 Tinea manuum Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 201000003875 tinea corporis Diseases 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a medicine for curing parapsoriasis, which is prepared from the following traditional Chinese medicines by ratio by weight: 20 to 30 of astragalus root, 10 to 20 of angelica, 10 to 20 of bupleurum root, 10 to 18 of stir-fried white peony root, 10 to18 of atractylodes rhizome, 10 to 20 of stiff silkworm, 10 to 18 of cicada molting, 10 to18 of safflower, 10 to 20 of raw coix, 10 to 20 of indigowoad root, 18 to 30 of dandehon herb and 15 to 30 of forsythia suspensa.
Description
The present invention is a kind of antipsoriatics thing, belongs to the field of Chinese medicines.
Psoriasis claims psoriasis again, is a kind of refractory skin that is difficult to cure.Treated psoriasis, doctor trained in Western medicine is mainly based on anti-folic acid class medicine for oral administration, as methotrexate, ethyliminum, bimolane etc. in the past.External used medicine mainly is a hormones.The Chinese traditional treatment typing differs, and comprehensively, mainly is to use the medicine of heat-clearing and toxic substances removing removing heat from blood, as Flos Lonicerae, the Radix Rehmanniae, Rhizoma Smilacis Glabrae etc.But mostly be short term efficacy, and curative effect is difficult to control, recurrence easily.
The object of the invention provides a kind ofly can treat the psoriasic Chinese medicine of parapsoriasis.
The composition of medicine of the present invention is made of by weight following medicine:
Radix Astragali 20-30
Radix Angelicae Sinensis 10-20
Radix Bupleuri 10-20
Radix Paeoniae Alba (parched) 10-18
Rhizoma Atractylodis 10-18
Bombyx Batryticatus 10-20
Periostracum Cicadae 10-18
Flos Carthami 10-18
Raw pearl barley 10-20
Radix Isatidis 10-20
Herba Taraxaci 18-30
Fructus Forsythiae 15-30
The weight ratio that said medicine is formed is preferably:
The Radix Astragali 25
Radix Angelicae Sinensis 15
Radix Bupleuri 15
Radix Paeoniae Alba (parched) 12
Rhizoma Atractylodis 12
Bombyx Batryticatus 15
Periostracum Cicadae 12
Flos Carthami 12
Raw pearl barley 15
Radix Isatidis 15
Herba Taraxaci 20
Fructus Forsythiae 20
Medicine of the present invention can be prepared into the common drug dosage form according to the formulation method of routine.
The preparation method of medicine capsule of the present invention is:
Choose Chinese crude drug by the said medicine composition, screening is cleaned, and concocts, and drying is pulverized, and sieves, and is encapsulated.
Medicine of the present invention has QI and blood regulating, soothing liver-QI and transfers the dispel function of tinea of spleen, promoting blood circulation and stopping pain, dispelling wind for relieving itching, toxin expelling, cures mainly diseases such as parapsoriasis, tinea corporis, tinea capitis, tinea manus and pedis.
Drug therapy psoriasis of the present invention and all kinds of ringworm are remarkably productive, now clinical application effect are summarized as follows:
Since year March in March, 1996 to 1999, with Drug therapy of the present invention dissimilar ringworms, accumulative total has been accepted 1800 routine patients for medical treatment.Having carried out treatment observes.Proved that medicine of the present invention has original curative effect to all kinds of ringworms.Simultaneously also brought the convenience of taking medicine to the patient.And good social benefit and economic benefit have been produced.Curative effect is summed up and is seen the following form:
The clinical efficacy summary sheet
| The sick kind | Case load | Cure | Produce effects | Effectively | Invalid | Effective percentage |
| Parapsoriasis and other tinea | 1800 | 603 | 911 | 223 | 63 | 96.5 |
Embodiment
Medicine is formed:
The Radix Astragali 25 grams
Radix Angelicae Sinensis 15 grams
Radix Bupleuri 15 grams
Radix Paeoniae Alba (parched) 12 grams
Rhizoma Atractylodis 12 grams
Bombyx Batryticatus 15 grams
Periostracum Cicadae 12 grams
Flos Carthami 12 grams
Raw pearl barley 15 grams
Radix Isatidis 15 grams
Herba Taraxaci 20 grams
Fructus Forsythiae 20 grams
Choose medicine by above-mentioned composition, screening, cleaning, drying are pulverized, and cross 100 mesh sieves, and are encapsulated.
Claims (2)
1, a kind of medicine for the treatment of parapsoriasis is characterized in that it is to be made by the Chinese medicine of following weight ratio:
Radix Astragali 20-30
Radix Angelicae Sinensis 10-20
Radix Bupleuri 10-20
Radix Paeoniae Alba (parched) 10-18
Rhizoma Atractylodis 10-18
Bombyx Batryticatus 10-20
Periostracum Cicadae 10-18
Flos Carthami 10-18
Raw pearl barley 10-20
Radix Isatidis 10-20
Herba Taraxaci 18-30
Fructus Forsythiae 15-30
2,, it is characterized in that the weight ratio that said medicine is formed is according to the medicine of claim 1:
The Radix Astragali 25
Radix Angelicae Sinensis 15
Radix Bupleuri 15
Radix Paeoniae Alba (parched) 12
Rhizoma Atractylodis 12
Bombyx Batryticatus 15
Periostracum Cicadae 12
Flos Carthami 12
Raw pearl barley 15
Radix Isatidis 15
Herba Taraxaci 20
Fructus Forsythiae 20
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00100276A CN1099876C (en) | 2000-01-13 | 2000-01-13 | Medicine for curing psoriasis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00100276A CN1099876C (en) | 2000-01-13 | 2000-01-13 | Medicine for curing psoriasis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1262936A CN1262936A (en) | 2000-08-16 |
| CN1099876C true CN1099876C (en) | 2003-01-29 |
Family
ID=4575359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN00100276A Expired - Fee Related CN1099876C (en) | 2000-01-13 | 2000-01-13 | Medicine for curing psoriasis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1099876C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105327020A (en) * | 2015-12-01 | 2016-02-17 | 陈焕斌 | Traditional Chinese medicine for treating parapsoriasis |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2845603A1 (en) * | 2002-10-10 | 2004-04-16 | Herose Pharma Internat Pte Lts | Composition, useful in the treatment of psoriasis, comprises e.g., Gan Jiang (dried ginger), Dan Shen (Danshen root/red sage) and Jiang Xiang (rosewood heart wood) |
| CN103239685B (en) * | 2013-05-25 | 2015-01-28 | 张群 | Chinese medicine composition for treating psoriasis |
-
2000
- 2000-01-13 CN CN00100276A patent/CN1099876C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105327020A (en) * | 2015-12-01 | 2016-02-17 | 陈焕斌 | Traditional Chinese medicine for treating parapsoriasis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1262936A (en) | 2000-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1150922C (en) | A medicated liquor for treating arthralgia syndrome such as rheumatism and rheumatoid diseases | |
| CN1365827A (en) | Exterior-applied medicine for treating osteopathy | |
| CN1695694A (en) | Chinese traditional medicine for treating breast disease and preparing technique | |
| CN1054773C (en) | Chinese patent drug "Bizhengning" for treatment of arthralgia-syndrome | |
| CN1099876C (en) | Medicine for curing psoriasis | |
| CN1245173C (en) | Medicine composition for treating liver fibrillation and liver cirrhosis and its prepn process | |
| CN1943764A (en) | The Chinese herbal medicinal pills for treatment of hepatitis B and liver cancer | |
| CN1686504A (en) | Anti-inflammatory clear belt soup | |
| CN1111033C (en) | Psoriasis treating medicine | |
| CN1319590C (en) | Chinese medicinal preparation for treating hepatitis and preparation method thereof | |
| CN1175841C (en) | Chinese medicine for treating tinea and antipruritic | |
| CN1053587C (en) | Chinese patent drug | |
| CN1181878C (en) | Detumescence plaster | |
| CN1099874C (en) | Acne treating medicine | |
| CN1163251C (en) | Weishukang for treating gastrosis | |
| CN101138625A (en) | Traditional Chinese medicine composition for treating shoulder arthritis | |
| CN1111032C (en) | Alopecia treating medicine | |
| CN1099875C (en) | Dermatosis treating medicine | |
| CN1141114C (en) | Tendon-conditioning analgetic | |
| CN1111031C (en) | Medicine for treating leukoderma | |
| CN1385203A (en) | Compound Chinese medicine preparation of damnacanthus | |
| CN1124853C (en) | Ointment for treating protrusion of lumber intervertebral disc and its preparation | |
| CN1377672A (en) | Rheumatic pain killing preparation | |
| CN1092971C (en) | Chinese medicine for treating rheumatism | |
| CN1054986C (en) | Chinese medicine pill for treating rheumatoid disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |